FILANA THERAPEUTICS, INC. (FLNA) Stock

FILANA THERAPEUTICS, INC. (FLNA) is a Healthcare stock trading at $0.96 (as of 2026-08-21), with a market capitalization of $46.27M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Valuation — source: SEC EDGAR (first-party)
Price$0.96
Market Cap$46.27M
Price / Book0.68
FCF Yield-108.5%
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.7
Industry P/E (Pharmaceutical Products)17.0
Company
SectorHealthcare
IndustryPharmaceutical Products

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • TransCode Therapeutics, Inc. (RNAZ)
  • Hyperion DeFi, Inc. (HYPD)
  • Tenax Therapeutics, Inc. (TENX)
  • Grace Therapeutics, Inc. (GRCE)
  • Seres Therapeutics, Inc. (MCRB)
  • Karyopharm Therapeutics Inc. (KPTI)
  • Silo Pharma, Inc. (SILO)
  • Veru Inc. (VERU)
FLNA earnings history · FLNA institutional & insider holders · FLNA KPIs & operating metrics · FLNA financials · FLNA investor presentations & press releases · FLNA SEC filings · FLNA peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.